Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Ghana strike ends but election campaign to test IMF deal further
30 Aug 2015 at 7:11am
By Matthew Mpoke Bigg ACCRA (Reuters) - Ghana faced down the first major challenge to an IMF austerity programme on Monday when doctors suspended a three-week strike but a bigger test of President John Mahama's commitment will come next year as he fights for reelection. The International Monetary Fund deal is designed to restore fiscal stability and kickstart growth in a country that recently lost its reputation as one of Africa's strongest economies after years in which its GDP grew at around 8 percent thanks to exports of gold, cocoa and oil. The end of the strike by the Ghana Medical Association makes it easier for the government to honour the $918 million IMF programme in the short-term.
Neurologist, author Oliver Sacks dies at age 82: New York Times
30 Aug 2015 at 6:42am
Dr. Oliver Sacks, the neurologist who studied the intricacies of the brain and wrote eloquently about them in books such as "Awakenings" and "The Man Who Mistook His Wife for a Hat," died on Sunday at the age of 82, the New York Times reported. The British-born Sacks, who announced in February 2015 that he had terminal liver cancer, died at his home in New York City, his longtime personal assistant Kate Edgar told the Times. Sacks was called "a kind of poet laureate of medicine" and "one of the great clinical writers of the 20th century" by the New York Times.
Study: Tiny, wireless pacemaker could be surgery-free option
30 Aug 2015 at 4:45am
LONDON (AP) ? A tiny, wireless pacemaker could offer some heart patients a surgery-free alternative to the traditional devices, a new study says. Some doctors, however, say there are lingering safety questions and warned patients not to rush to get the new technology.
Alnylam, Medicines cholesterol drug lasts months after one shot
30 Aug 2015 at 12:38am
By Ben Hirschler LONDON (Reuters) - A new drug in early development cuts cholesterol as much as two potent injections recently cleared for sale but lasts much longer, meaning it may need to be given only every three to six months, initial findings suggest. Results with Alnylam Pharmaceuticals and Medicines Co's experimental product ALN-PCSsc highlight the competition for a market tipped to generate billions of dollars in sales. Unlike rival antibody-based PCSK9 medicines that work in the blood, the new under-the-skin injection is a first-in-class treatment that stops synthesis of the protein which is linked to "bad" LDL cholesterol in the liver.
Why Bernie Sanders Is Best on Women's Issues
29 Aug 2015 at 11:45am
Women's issues are taking center stage in the lead-up to 2016. As they should: The conservative war on women's health and reproductive rights has raged on for far too long. And in all measures of social and political inequality, we remain what number-crunchers coolly term "disproportionately affected."Many people believe that electing a woman...
Planned Parenthood goes to court to fight funding cuts in Alabama
29 Aug 2015 at 9:08am
By Letitia Stein (Reuters) - (This 28 August 2015 story was refiled to add the dropped word "court" in the first paragraph) Planned Parenthood filed a complaint in Alabama federal court on Friday seeking to stop the state from defunding its health clinics after the release of covertly recorded videos attacking the organization's handling of aborted fetal tissue. The reproductive-health organization took similar legal action earlier this week in Louisiana, which also plans to terminate its contract with Planned Parenthood to provide medical services to low-income residents. Planned Parenthood, joined in the suit by the American Civil Liberties Union, said in court filings that Alabama's Republican governor illegally terminated its contract to provide health services under Medicaid, a federal and state healthcare program for the poor.
Rio 2016 organizers 'extremely concerned' over sick sailor
29 Aug 2015 at 8:27am
By Karolos Grohmann BERLIN (Reuters) - Organizers of the Rio de Janeiro 2016 Olympics said on Saturday they were "extremely concerned" after German sailor Erik Heil fell ill following his third place at the test event there. Heil, who is being treated in a Berlin hospital for several infections, said he was convinced they were caused by the polluted waters, piling more pressure on organizers to secure the safety of the athletes at next year's Olympic sailing, swimming and triathlon events. "We were extremely concerned when we learned of the hospital admission of athlete Erik Heil," organizers said in a statement sent to Reuters.
Olympics-Rio 2016 organisers "extremely concerned" over sick sailor
29 Aug 2015 at 8:20am
By Karolos Grohmann BERLIN, Aug 29 (Reuters) - Organisers of the Rio de Janeiro 2016 Olympics said on Saturday they were "extremely concerned" after German sailor Erik Heil fell ill following his third place at the test event there. Heil, who is being treated in a Berlin hospital for several infections, said he was convinced they were caused by the polluted waters, piling more pressure on organisers to secure the safety of the athletes at next year's Olympic sailing, swimming and triathlon events. "We were extremely concerned when we learned of the hospital admission of athlete Erik Heil," organisers said in a statement sent to Reuters.
ICYMI: New Orleans' Coroner And The Pros And Cons Of Egg Freezing
29 Aug 2015 at 7:50am
ICYMI Health features what we're reading this week.This week, on the tenth anniversary of Hurricane Katrina hitting New Orleans, we listened to a radio interview with the city's coroner, a position that requires making tough judgement calls about classifying police-involved shooting deaths, as well as consoling families of the deceased. We...
European heart experts okay longer use of blood thinners
29 Aug 2015 at 6:27am
European heart experts on Saturday endorsed the potential use of multiple blood thinning drugs for heart attack patients beyond one year, in a move that may boost demand for AstraZeneca's Brilinta. New European Society of Cardiology (ESC) guidelines state for the first time that use of so-called P2Y12 inhibitors in addition to aspirin beyond one year "may be considered after careful assessment of the ischaemic and bleeding risks of the patient". The move follows an assessment of two large clinical trials, known as PEGASUS and DAPT, showing that prolonged dual drug treatment can reduce the risk of repeat heart attacks or strokes in patients with previous heart problems.
The Perils of Our 'On-Call' Work Culture
28 Aug 2015 at 2:36pm
In my work as an executive coach and keynote, clients and audience members frequently talk about their lack of "downtime." Even when they are home, there is rarely a sense of relief from work.In a recent investigation, researchers were curious about how being "on-call" affected various health indicators. Studying a group of shift workers...
Healthy workplace tied to fewer obese young workers
28 Aug 2015 at 2:26pm
By Janice Neumann (Reuters Health) - Workplaces that encourage healthy lifestyle practices are tied to fewer obese employees among millennials, according to a new study. About 17 percent of young employees in workplaces that encouraged several healthy lifestyle practices were obese, compared to about 24 percent in spaces that promoted one or no healthy practices, researchers found. ?I have personally experienced a range of workplace environments that I feel have influenced my eating habits and my physical activity, both positively and negatively," said lead author Allison Watts, of the School of Public Health at the University of Minnesota in Minneapolis.
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
28 Aug 2015 at 1:44pm
(Reuters) - A class of diabetes drugs that include Merck & Co Inc's Januvia has been linked with severe joint pain, the U.S. Food and Drug Administration said on Friday. The FDA said it had identified 33 cases of severe joint pain in patients taking a class of drugs known as DPP-4 inhibitors between Oct. 16, 2006, when the first one was approved, through Dec. 31, 2013. Five cases were reported with AstraZeneca Plc's Onglyza (saxagliptin), two with Boehringer Ingelheim's Tradjenta (linagliptin), and one with Takeda Pharmaceutical's Nesina (alogliptin).
On the Way to a National Destination Dignity
28 Aug 2015 at 1:30pm
On Monday August 24, 2015, a historic moment happened in Washington when people living with mental health conditions from all over the nation, along with dozens of diverse organizations, gathered to raise public awareness for change. At the National Mall, leaders rallied hundreds to challenge the prejudice and fear they so often face, marching...
Caffeine may chip a couple strokes off golf score
28 Aug 2015 at 1:00pm
Professional golfers may walk up to five miles over four hours for a round of golf, which is physical activity, though not intense exercise, said senior author Dr. Kaelin C. Young of the Edward Via College of Osteopathic Medicine, also on the Auburn campus. A golf tournament involves physical and mental fatigue, Young said. The researchers studied 12 male golfers with a handicap of three to 18 as they played an 18-hole round of golf on two consecutive days for a 36-hole tournament.